Gastrins, iron homeostasis and colorectal cancer

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 5, 2011, Pages 889-895

  Kovac, Suzana ^a   Anderson, Gregory J ^b   Baldwin, Graham S ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Colon cancer; Colorectal cancer; Ferric; Gastrin; Iron

Indexed keywords

FERRIC ION; FERROPORTIN; GASTRIN; GASTRIN RECEPTOR; IRON; TRANSFERRIN;

BINDING AFFINITY; COLORECTAL CANCER; GASTRIN BLOOD LEVEL; HEMOCHROMATOSIS; HOMEOSTASIS; HORMONE ACTION; HUMAN; IN VITRO STUDY; IN VIVO CULTURE; INTESTINE CELL; IRON BINDING CAPACITY; IRON HOMEOSTASIS; IRON STORAGE; IRON TRANSPORT; NONHUMAN; PRIORITY JOURNAL; REVIEW; STOMACH ACID SECRETION;

ANIMALS; BIOLOGICAL TRANSPORT; COLORECTAL NEOPLASMS; GASTRINS; HOMEOSTASIS; HUMANS; IRON; RECEPTOR, CHOLECYSTOKININ B;

MUS;

EID: 79955648151     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2011.02.007     Document Type: Review

References (105)

1. Edkins J.S. On the chemical mechanism of gastric secretion. Proc. Roy. Soc. B 1905, 76:376.
2. Baird I.M., Blackburn E.K., Wilson G.M. The pathogenesis of anaemia after partial gastrectomy: I. Development of anaemia in relation to time after operation, blood loss, and diet. Q. J. Med. 1959, 28:21-34.
3. Baird I.M., Wilson G.M. The pathogenesis of anaemia after partial gastrectomy: II. Iron absorption after partial gastrectomy. Q. J. Med. 1959, 28:35-41.
4. Baldwin G.S., Curtain C.C., Sawyer W.H. Selective, high-affinity binding of ferric ions by glycine-extended gastrin(17). Biochemistry 2001, 40:10741-10746.
5. Smith K.A., Kovac S., Anderson G.J., Shulkes A., Baldwin G.S. Circulating gastrin is increased in hemochromatosis. FEBS Lett. 2006, 580:6195-6198.
6. Kovac S., Smith K., Anderson G.J., Burgess J.R., Shulkes A., Baldwin G.S. Interrelationships between circulating gastrin and iron status in mice and humans. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 295:G855-G861.
7. Aly A., Shulkes A., Baldwin G.S. Gastrins, cholecystokinins and gastrointestinal cancer. Biochim. Biophys. Acta 2004, 1704:1-10.
8. Ferrand A., Wang T.C. Gastrin and cancer: a review. Cancer Lett. 2006, 238:15-29.
9. Gregory R.A., Tracy H.J. The constitution and properties of two gastrins extracted from hog antral mucosa. Gut 1964, 5:103-114.
10. Gregory H., Hardy P.M., Jones D.S., Kenner G.W., Sheppard R.C. The antral hormone gastrin. Structure of gastrin. Nature 1964, 204:931-933.
11. Yoo O.J., Powell C.T., Agarwal K.L. Molecular cloning and nucleotide sequence of full-length of cDNA coding for porcine gastrin. Proc. Natl. Acad. Sci. USA 1982, 79:1049-1053.
12. Dockray G.J., Varro A., Dimaline R., Wang T. The gastrins: their production and biological activities. Annu. Rev. Physiol. 2001, 63:119-139.
13. Kovac S., Shulkes A., Baldwin G.S. Peptide processing and biology in human disease. Curr. Opin. Endocrinol. Diabet. Obes. 2009, 16:79-85.
14. Shulkes A., Baldwin G.S. Biology of gut cholecystokinin and gastrin receptors. Clin. Exp. Pharmacol. Physiol. 1997, 24:209-216.
15. Morley J.S., Tracy H.J., Gregory R.A. Structure-function relationships in the active C-terminal tetrapeptide sequence of gastrin. Nature 1965, 207:1356-1359.
16. Kovac S., Xiao L., Shulkes A., Patel O., Baldwin G.S. Gastrin increases its own synthesis in gastrointestinal cancer cells via the CCK2 receptor. FEBS Lett. 2010, 584:4413-4418.
17. Wang T.C., Koh T.J., Varro A., Cahill R.J., Dangler C.A., Fox J.G., Dockray G.J. Processing and proliferative effects of human progastrin in transgenic mice. J. Clin. Invest. 1996, 98:1918-1929.
18. Koh T.J., Goldenring J.R., Ito S., Mashimo H., Kopin A.S., Varro A., Dockray G.J., Wang T.C. Gastrin deficiency results in altered gastric differentiation and decreased colonic proliferation in mice. Gastroenterology 1997, 113:1015-1025.
19. Koh T.J., Dockray G.J., Varro A., Cahill R.J., Dangler C.A., Fox J.G., Wang T.C. Overexpression of glycine-extended gastrin in transgenic mice results in increased colonic proliferation. J. Clin. Invest. 1999, 103:1119-1126.
20. Aly A., Shulkes A., Baldwin G.S. Short term infusion of glycine-extended gastrin(17) stimulates both proliferation and formation of aberrant crypt foci in rat colonic mucosa. Int. J. Cancer 2001, 94:307-313.
21. Baldwin G.S. Antiproliferative gastrin/cholecystokinin receptor antagonists target the 78-kDa gastrin-binding protein. Proc. Natl. Acad. Sci. USA 1994, 91:7593-7597.
22. Singh P., Wu H., Clark C., Owlia A. Annexin II binds progastrin and gastrin-like peptides, and mediates growth factor effects of autocrine and exogenous gastrins on colon cancer and intestinal epithelial cells. Oncogene 2007, 26:425-440.
23. Baldwin G.S., Hollande F., Yang Z., Karelina Y., Paterson A., Strang R., Fourmy D., Neumann G., Shulkes A. Biologically active recombinant human progastrin(6-80) contains a tightly bound calcium ion. J. Biol. Chem. 2001, 276:7791-7796.
24. Dubeykovskiy A., Nguyen T., Dubeykovskaya Z., Lei S., Wang T.C. Flow cytometric detection of progastrin interaction with gastrointestinal cells. Regul. Pept. 2008, 151:106-114.
25. Seva C., Dickinson C.J., Yamada T. Growth-promoting effects of glycine-extended progastrin. Science 1994, 265:410-412.
26. Obrink K.J. Histamine and gastric acid secretion. A review. Scand. J. Gastroenterol. Suppl. 1991, 180:4-8.
27. Chuang C.N., Chen M.C., Soll A.H. The pathways regulating acid secretion: the view from the isolated cell. Yale J. Biol. Med. 1994, 67:107-112.
28. Hakanson R., Ding X.Q., Norlen P., Lindstrom E. CCK2 receptor antagonists: pharmacological tools to study the gastrin-ECL cell-parietal cell axis. Regul. Pept. 1999, 80:1-12.
29. Higashide S., Gomez G., Greeley G.H., Townsend C.M., Thompson J.C. Glycine-extended gastrin potentiates gastrin-stimulated gastric acid secretion in rats. Am. J. Physiol. 1996, 270:G220-G224.
30. Cui G., Koh T.J., Chen D., Zhao C.M., Takaishi S., Dockray G.J., Varro A., Rogers A.B., Fox J.G., Wang T.C. Overexpression of glycine-extended gastrin inhibits parietal cell loss and atrophy in the mouse stomach. Cancer Res. 2004, 64:8160-8166.
31. Friis-Hansen L., Sundler F., Li Y., Gillespie P.J., Saunders T.L., Greenson J.K., Owyang C., Rehfeld J.F., Samuelson L.C. Impaired gastric acid secretion in gastrin-deficient mice. Am. J. Physiol. 1998, 274:G561-G568.
32. Nagata A., Ito M., Iwata N., Kuno J., Takano H., Minowa O., Chihara K., Matsui T., Noda T. G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo. Proc. Natl. Acad. Sci. USA 1996, 93:11825-11830.
33. Langhans N., Rindi G., Chiu M., Rehfeld J.F., Ardman B., Beinborn M., Kopin A.S. Abnormal gastric histology and decreased acid production in cholecystokinin-B/gastrin receptor-deficient mice. Gastroenterology 1997, 112:280-286.
34. Schade S.G., Cohen R.J., Conrad M.E. Effect of hydrochloric acid on iron absorption. N. Engl. J. Med. 1968, 279:672-674.
35. Conrad M.E., Schade S.G. Ascorbic acid chelates in iron absorption: a role for hydrochloric acid and bile. Gastroenterology 1968, 55:35-45.
36. Bezwoda W., Charlton R., Bothwell T., Torrance J., Mayet F. The importance of gastric hydrochloric acid in the absorption of nonheme food iron. J. Lab. Clin. Med. 1978, 92:108-116.
37. Conrad M.E., Parmley R.T., Osterloh K. Small intestinal regulation of iron absorption in the rat. J. Lab. Clin. Med. 1987, 110:418-426.
38. Stewart C.A., Termanini B., Sutliff V.E., Serrano J., Yu F., Gibril F., Jensen R.T. Iron absorption in patients with Zollinger-Ellison syndrome treated with long-term gastric acid antisecretory therapy Aliment. Pharmacol. Ther. 1998, 12:83-98.
39. Hobbs J.R. Iron deficiency after partial gastrectomy. Gut 1961, 2:141-149.
40. Turnberg L.A. The absorption of iron after partial gastrectomy. Q. J. Med. 1966, 35:107-118.
41. Hines J.D., Hoffbrand A.V., Mollin D.L. The hematologic complications following partial gastrectomy. A study of 292 patients. Am. J. Med. 1967, 43:555-569.
42. Wheldon E.J., Venables C.W., Johnston I.D. The relationship of gastric secretion to anemia over 15years following vagotomy and gastroenterostomy. Gut 1970, 11:1056.
43. Goldberg A., Lochhead A.C., Dagg J.H. Histamine-fast achlorhydria and iron absorption. Lancet 1963, 1:848-850.
44. Cook J.D., Brown G.M., Valberg L.S. The effect of achylia gastrica on iron absorption. J. Clin. Invest. 1964, 43:1185-1191.
45. Jacobs A., Rhodes J., Peters D.K., Campbell H., Eakins J.D. Gastric acidity and iron absorption. Br. J. Haematol. 1966, 12:728-736.
46. Skikne B.S., Lynch S.R., Cook J.D. Role of gastric acid in food iron absorption. Gastroenterology 1981, 81:1068-1071.
47. Golubov J., Flanagan P., Adams P. Inhibition of iron absorption by omeprazole in rat model. Dig. Dis. Sci. 1991, 36:405-408.
48. Koop H. Review article: metabolic consequences of long-term inhibition of acid secretion by omeprazole. Aliment. Pharmacol. Ther. 1992, 6:399-406.
49. Sharma V.R., Brannon M.A., Carloss E.A. Effect of omeprazole on oral iron replacement in patients with iron deficiency anemia. S. Med. J. 2004, 97:887-889.
50. McKie A.T., Barrow D., Latunde-Dada G.O., Rolfs A., Sager G., Mudaly E., Mudaly M., Richardson C., Barlow D., Bomford A., Peters T.J., Raja K.B., Shirali S., Hediger M.A., Farzaneh F., Simpson R.J. An iron-regulated ferric reductase associated with the absorption of dietary iron. Science 2001, 291:1755-1759.
51. Gunshin H., Starr C.N., Direnzo C., Fleming M.D., Jin J., Greer E.L., Sellers V.M., Galica S.M., Andrews N.C. Cybrd1 (duodenal cytochrome b) is not necessary for dietary iron absorption in mice. Blood 2005, 106:2879-2883.
52. Gunshin H., Mackenzie B., Berger U.V., Gunshin Y., Romero M.F., Boron W.F., Nussberger S., Gollan J.L., Hediger M.A. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997, 388:482-488.
53. McKie A.T., Marciani P., Rolfs A., Brennan K., Wehr K., Barrow D., Miret S., Bomford A., Peters T.J., Farzaneh F., Hediger M.A., Hentze M.W., Simpson R.J. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol. Cell 2000, 5:299-309.
54. Donovan A., Lima C.A., Pinkus J.L., Pinkus G.S., Zon L.I., Robine S., Andrews N.C. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab. 2005, 1:191-200.
55. Vulpe C.D., Kuo Y.M., Murphy T.L., Cowley L., Askwith C., Libina N., Gitschier J., Anderson G.J. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat. Genet. 1999, 21:195-199.
56. Harris Z.L., Durley A.P., Man T.K., Gitlin J.D. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc. Natl. Acad. Sci. USA 1999, 96:10812-10817.
57. Cherukuri S., Potla R., Sarkar J., Nurko S., Harris Z.L., Fox P.L. Unexpected role of ceruloplasmin in intestinal iron absorption. Cell Metab. 2005, 2:309-319.
58. Park C.H., Valore E.V., Waring A.J., Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J. Biol. Chem. 2001, 276:7806-7810.
59. Nicolas G., Bennoun M., Devaux I., Beaumont C., Grandchamp B., Kahn A., Vaulont S. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc. Natl. Acad. Sci. USA 2001, 98:8780-8785.
60. Pigeon C., Ilyin G., Courselaud B., Leroyer P., Turlin B., Brissot P., Loreal O. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J. Biol. Chem. 2001, 276:7811-7819.
61. Ilyin G., Courselaud B., Troadec M.B., Pigeon C., Alizadeh M., Leroyer P., Brissot P., Loreal O. Comparative analysis of mouse hepcidin 1 and 2 genes: evidence for different patterns of expression and co-inducibility during iron overload. FEBS Lett. 2003, 542:22-26.
62. Nicolas G., Chauvet C., Viatte L., Danan J.L., Bigard X., Devaux I., Beaumont C., Kahn A., Vaulont S. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J. Clin. Invest. 2002, 110:1037-1044.
63. Roetto A., Papanikolaou G., Politou M., Alberti F., Girelli D., Christakis J., Loukopoulos D., Camaschella C. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat. Genet. 2003, 33:21-22.
64. Nemeth E., Tuttle M.S., Powelson J., Vaughn M.B., Donovan A., Ward D.M., Ganz T., Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004, 306:2090-2093.
65. Papanikolaou G., Tzilianos M., Christakis J.I., Bogdanos D., Tsimirika K., MacFarlane J., Goldberg Y.P., Sakellaropoulos N., Ganz T., Nemeth E. Hepcidin in iron overload disorders. Blood 2005, 105:4103-4105.
66. Peyssonnaux C., Zinkernagel A.S., Schuepbach R.A., Rankin E., Vaulont S., Haase V.H., Nizet V., Johnson R.S. Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). J. Clin. Invest. 2007, 117:1926-1932.
67. Wessling-Resnick M. Iron transport. Annu. Rev. Nutr. 2000, 20:129-151.
68. Robb A., Wessling-Resnick M. Regulation of transferrin receptor 2 protein levels by transferrin. Blood 2004, 104:4294-4299.
69. Johnson M.B., Enns C.A. Diferric transferrin regulates transferrin receptor 2 protein stability. Blood 2004, 104:4287-4293.
70. Kawabata H., Germain R.S., Vuong P.T., Nakamaki T., Said J.W., Koeffler H.P. Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo. J. Biol. Chem. 2000, 275:16618-16625.
71. Camaschella C., Roetto A., Cali A., De Gobbi M., Garozzo G., Carella M., Majorano N., Totaro A., Gasparini P. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat. Genet. 2000, 25:14-15.
72. Knutson M.D. Iron-sensing proteins that regulate hepcidin and enteric iron absorption. Annu. Rev. Nutr. 2010, 30:149-171.
73. Frazer D.M., Anderson G.J. The orchestration of body iron intake: how and where do enterocytes receive their cues?. Blood Cells Mol. Dis. 2003, 30:288-297.
74. Goswami T., Andrews N.C. Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing. J. Biol. Chem. 2006, 281:28494-28498.
75. Wallace D.F., Summerville L., Crampton E.M., Frazer D.M., Anderson G.J., Subramaniam V.N. Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload. Hepatology 2009, 50:1992-2000.
76. Pannequin J., Barnham K.J., Hollande F., Shulkes A., Norton R.S., Baldwin G.S. Ferric ions are essential for the biological activity of the hormone glycine-extended gastrin. J. Biol. Chem. 2002, 277:48602-48609.
77. He H., Shehan B.P., Barnham K.J., Norton R.S., Shulkes A., Baldwin G.S. Biological activity and ferric ion binding of fragments of glycine-extended gastrin. Biochemistry 2004, 43:11853-11861.
78. Ferrand A., Lachal S., Bramante G., Kovac S., Shulkes A., Baldwin G.S. Stimulation of proliferation in the colorectal mucosa by gastrin precursors is blocked by desferrioxamine. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 299:G220-G227.
79. Pannequin J., Kovac S., Tantiongco J.P., Norton R.S., Shulkes A., Barnham K.J., Baldwin G.S. A novel effect of bismuth ions: selective inhibition of the biological activity of glycine-extended gastrin. J. Biol. Chem. 2004, 279:2453-2460.
80. Baldwin G.S., Chandler R., Weinstock J. Binding of gastrin to gastric transferrin. FEBS Lett. 1986, 205:147-149.
81. Longano S.C., Knesel J., Howlett G.J., Baldwin G.S. Interaction of gastrin with transferrin: effects of ferric ions. Arch. Biochem. Biophys. 1988, 263:410-417.
82. Kovac S., Ferrand A., Estève J.-P., Mason A., Baldwin G.S. Definition of the Residues Required for the Interaction between Glycine-extended Gastrin and Transferrin In Vitro. FEBS J. 2009, 276:4866-4874.
83. Friis-Hansen L., Rieneck K., Nilsson H.O., Wadstrom T., Rehfeld J.F. Gastric inflammation, metaplasia, and tumor development in gastrin-deficient mice. Gastroenterology 2006, 131:246-258.
84. Watson S.A., Grabowska A.M., El-Zaatari M., Takhar A. Gastrin - active participant or bystander in gastric carcinogenesis?. Nat. Rev. Cancer 2006, 6:936-946.
85. Van Solinge W.W., Nielsen F.C., Friis-Hansen L., Falkmer U.G., Rehfeld J.F. Expression but incomplete maturation of progastrin in colorectal carcinomas. Gastroenterology 1993, 104:1099-1107.
86. Ciccotosto G.D., McLeish A., Hardy K.J., Shulkes A. Expression, processing, and secretion of gastrin in patients with colorectal carcinoma. Gastroenterology 1995, 109:1142-1153.
87. Thorburn C.M., Friedman G.D., Dickinson C.J., Vogelman J.H., Orentreich N., Parsonnet J. Gastrin and colorectal cancer: a prospective study. Gastroenterology 1998, 115:275-280.
88. Koh T.J., Bulitta C.J., Fleming J.V., Dockray G.J., Varro A., Wang T.C. Gastrin is a target of the beta-catenin/TCF-4 growth-signaling pathway in a model of intestinal polyposis. J. Clin. Invest. 2000, 106:533-539.
89. Singh P., Velasco M., Given R., Wargovich M., Varro A., Wang T.C. Mice overexpressing progastrin are predisposed for developing aberrant colonic crypt foci in response to AOM. Am. J. Physiol. Gastrointest. Liver Physiol. 2000, 278:G390-G399.
90. Singh P., Velasco M., Given R., Varro A., Wang T.C. Progastrin expression predisposes mice to colon carcinomas and adenomas in response to a chemical carcinogen. Gastroenterology 2000, 119:162-171.
91. Jin G., Ramanathan V., Quante M., Baik G.H., Yang X., Wang S.S., Tu S., Gordon S.A., Pritchard D.M., Varro A., Shulkes A., Wang T.C. Inactivating cholecystokinin-2 receptor inhibits progastrin-dependent colonic crypt fission, proliferation, and colorectal cancer in mice. J. Clin. Invest. 2009, 119:2691-2701.
92. Hollande F., Imdahl A., Mantamadiotis T., Ciccotosto G.D., Shulkes A., Baldwin G.S. Glycine-extended gastrin acts as an autocrine growth factor in a nontransformed colon cell line. Gastroenterology 1997, 113:1576-1588.
93. Kermorgant S., Lehy T. Glycine-extended gastrin promotes the invasiveness of human colon cancer cells. Biochem. Biophys. Res. Commun. 2001, 285:136-141.
94. Stepan V.M., Krametter D.F., Matsushima M., Todisco A., Delvalle J., Dickinson C.J. Glycine-extended gastrin regulates HEK cell growth. Am. J. Physiol. 1999, 277:R572-R581.
95. Singh P., Owlia A., Varro A., Dai B., Rajaraman S., Wood T. Gastrin gene expression is required for the proliferation and tumorigenicity of human colon cancer cells. Cancer Res. 1996, 56:4111-4115.
96. Watson S.A., Michaeli D., Grimes S., Morris T.M., Robinson G., Varro A., Justin T.A., Hardcastle J.D. Gastrimmune raises antibodies that neutralize amidated and glycine-extended gastrin-17 and inhibit the growth of colon cancer. Cancer Res. 1996, 56:880-885.
97. A.C. Chua, B. Klopcic, I.C. Lawrance, J.K. Olynyk, D. Trinder, Iron: an emerging factor in colorectal carcinogenesis, World J Gastroenterol. 16 663-672.
98. Stevens R.G., Jones D.Y., Micozzi M.S., Taylor P.R. Body iron stores and the risk of cancer. N. Engl. J. Med. 1988, 319:1047-1052.
99. Knekt P., Reunanen A., Takkunen H., Aromaa A., Heliovaara M., Hakulinen T. Body iron stores and risk of cancer. Int. J. Cancer 1994, 56:379-382.
100. Shaheen N.J., Silverman L.M., Keku T., Lawrence L.B., Rohlfs E.M., Martin C.F., Galanko J., Sandler R.S. Association between hemochromatosis (HFE) gene mutation carrier status and the risk of colon cancer. J. Natl Cancer Inst. 2003, 95:154-159.
101. Osborne N.J., Gurrin L.C., Allen K.J., Constantine C.C., Delatycki M.B., McLaren C.E., Gertig D.M., Anderson G.J., Southey M.C., Olynyk J.K., Powell L.W., Hopper J.L., Giles G.G., English D.R. HFE C282Y homozygotes are at increased risk of breast and colorectal cancer. Hepatology 2010, 51:1311-1318.
102. Brookes M.J., Hughes S., Turner F.E., Reynolds G., Sharma N., Ismail T., Berx G., McKie A.T., Hotchin N., Anderson G.J., Iqbal T., Tselepis C. Modulation of iron transport proteins in human colorectal carcinogenesis. Gut 2006, 55:1449-1460.
103. Pannequin J., Tantiongco J.P., Kovac S., Shulkes A., Baldwin G.S. Divergent roles for ferric ions in the biological activity of amidated and non-amidated gastrins. J. Endocrinol. 2004, 181:315-325.
104. Beale A.L., Penney M.D., Allison M.C. The prevalence of iron deficiency among patients presenting with colorectal cancer. Colorectal Dis. 2005, 7:398-402.
105. Allen K.J., Gurrin L.C., Constantine C.C., Osborne N.J., Delatycki M.B., Nicoll A.J., McLaren C.E., Bahlo M., Nisselle A.E., Vulpe C.D., Anderson G.J., Southey M.C., Giles G.G., English D.R., Hopper J.L., Olynyk J.K., Powell L.W., Gertig D.M. Iron-overload-related disease in HFE hereditary hemochromatosis. N. Engl. J. Med. 2008, 358:221-230.